Chemoselective Azo-Coupling Bioconjugation via Diazonium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioconjugation chemistries are limited by slow kinetics, the need for toxic catalysts, and lack of compatibility for simultaneous attachment of multiple entities at different sites, necessitating the development of rapid and chemoselective labeling strategies compatible with existing bioorthogonal chemistries.
Innovation Solution
A chemoselective rapid azo-coupling reaction (CRACR) using non-natural aromatic chemical moieties, such as 5-hydroxytryptophan, covalently coupled with diazonium compounds for site-specific bioconjugation of biomolecules, allowing for the attachment of various entities like drugs, fluorophores, and probes without the need for catalysts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If conventional bioconjugation chemistries are used, then bioorthogonal labeling can be achieved, but the reaction kinetics are slow and catalysts are required
Solution Approach 1:
The invention extracts and eliminates the catalyst component from the bioconjugation system by utilizing the inherent reactivity of diazonium compounds with electron-rich aromatic moieties. This extraction of the catalyst requirement directly resolves the contradiction by achieving fast kinetics without introducing additional complexity from catalyst systems.
Solution Approach 2:
The invention changes the chemical parameters by selecting specific electron-rich aromatic moieties (such as 5-hydroxytryptophan, tyrosine, tryptophan) that naturally exhibit high reactivity toward diazonium compounds. This parameter change in molecular electronics enables rapid reaction kinetics without requiring external catalysts, thus resolving the contradiction between speed and complexity.
2Adaptability or versatility
If multiple bioorthogonal chemistries are used for simultaneous labeling, then multiple entities can be attached, but compatibility issues arise between different chemistries
Solution Approach 1:
The invention creates a universal labeling platform where diazonium compounds can react with multiple types of electron-rich aromatic moieties (5-hydroxytryptophan, tyrosine, tryptophan) through the same azo-coupling mechanism. This multi-functionality allows simultaneous labeling at different sites with different aromatic residues using a single chemistry type, ensuring compatibility and resolving the contradiction between versatility and reliability.
3Manufacturing precision
If site-specific incorporation of non-natural amino acids is achieved, then precise labeling can be obtained, but the incorporation efficiency may be reduced
Solution Approach 1:
The invention uses natural aromatic amino acids (tyrosine, tryptophan) that are already efficiently incorporated by the cellular machinery, rather than relying on non-natural amino acid incorporation systems. This copying of natural residues maintains high productivity while achieving site-specific precision through controlled expression and post-translational modification or genetic code expansion to place these aromatic residues at specific locations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, chemoselective, and stable bioconjugation of proteins and other biomolecules, facilitating simultaneous attachment of multiple entities at distinct sites, with the ability to cleave the azo-linkage under specific conditions, enhancing the utility in protein modification and labeling applications.
Implementation Method 1
the non-natural aromatic chemical moiety is reactive with, and can be functionalized by, aromatic diazonium groups... the aromatic moiety is covalently coupled to a diazonium compound/group
Data Source
AI summary
Novel biomolecular conjugates containing non-natural aromatic chemical moieties covalently coupled to a diazonium compound and methods of their use are disclosed.